BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37174035)

  • 1.
    Mondol RK; Millar EKA; Graham PH; Browne L; Sowmya A; Meijering E
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
    Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
    Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
    Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
    Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
    Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
    EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of epidermal growth factor receptor mutation subtypes in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning.
    Zhang W; Wang W; Xu Y; Wu K; Shi J; Li M; Feng Z; Liu Y; Zheng Y; Wu H
    Lab Invest; 2024 Jun; ():102094. PubMed ID: 38871058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and Biomarker Supervised Deep Learning for Survival Prediction in Two Multicenter Breast Cancer Series.
    Bychkov D; Joensuu H; Nordling S; Tiulpin A; Kücükel H; Lundin M; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Lundin J; Linder N
    J Pathol Inform; 2022; 13():9. PubMed ID: 35136676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning.
    Jang HJ; Lee A; Kang J; Song IH; Lee SH
    World J Gastroenterol; 2020 Oct; 26(40):6207-6223. PubMed ID: 33177794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.
    Anand D; Kurian NC; Dhage S; Kumar N; Rane S; Gann PH; Sethi A
    J Pathol Inform; 2020; 11():19. PubMed ID: 33033656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Molecular Subtype Prediction on Pathological Images with Discriminative Patch Selection and Multi-Instance Learning.
    Liu H; Xu WD; Shang ZH; Wang XD; Zhou HY; Ma KW; Zhou H; Qi JL; Jiang JR; Tan LL; Zeng HM; Cai HJ; Wang KS; Qian YL
    Front Oncol; 2022; 12():858453. PubMed ID: 35494021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks.
    Weitz P; Wang Y; Kartasalo K; Egevad L; Lindberg J; Grönberg H; Eklund M; Rantalainen M
    Bioinformatics; 2022 Jun; 38(13):3462-3469. PubMed ID: 35595235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Molecular Phenotypes from Histopathology Images: A Transcriptome-Wide Expression-Morphology Analysis in Breast Cancer.
    Wang Y; Kartasalo K; Weitz P; Ács B; Valkonen M; Larsson C; Ruusuvuori P; Hartman J; Rantalainen M
    Cancer Res; 2021 Oct; 81(19):5115-5126. PubMed ID: 34341074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
    Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
    Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
    Su Z; Niazi MKK; Tavolara TE; Niu S; Tozbikian GH; Wesolowski R; Gurcan MN
    PLoS One; 2023; 18(4):e0283562. PubMed ID: 37014891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images.
    Wang X; Zou C; Zhang Y; Li X; Wang C; Ke F; Chen J; Wang W; Wang D; Xu X; Xie L; Zhang Y
    Front Genet; 2021; 12():661109. PubMed ID: 34354733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.
    Yang J; Ju J; Guo L; Ji B; Shi S; Yang Z; Gao S; Yuan X; Tian G; Liang Y; Yuan P
    Comput Struct Biotechnol J; 2022; 20():333-342. PubMed ID: 35035786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
    Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
    JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.